202 related articles for article (PubMed ID: 4567562)
41. Reappraisal of the use of methotrexate in rheumatic disease.
Willkens RF
Am J Med; 1983 Oct; 75(4B):19-25. PubMed ID: 6356904
[TBL] [Abstract][Full Text] [Related]
42. Liver disease associated with methotrexate treatment of psoriatic patients.
Dubin HV; Harrell ER
Arch Dermatol; 1970 Nov; 102(5):498-503. PubMed ID: 5474111
[No Abstract] [Full Text] [Related]
43. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Berkowitz RS; Goldstein DP
Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
[TBL] [Abstract][Full Text] [Related]
44. Liver biopsies in patients on methotrexate for the treatment of psoriasis.
Callen JP; Hanno R
Int J Dermatol; 1980 May; 19(4):215. PubMed ID: 7399793
[No Abstract] [Full Text] [Related]
45. Methotrexate for psoriasis.
Weinstein GD
JAMA; 1973 Jul; 225(4):412. PubMed ID: 4741015
[No Abstract] [Full Text] [Related]
46. [Adverse effects of conventional DMARDs and biologic DMARDs].
Suzuki Y; Saito E; Wakabayashi T; Suwa A
Nihon Rinsho; 2007 Oct; 65 Suppl 8():209-17. PubMed ID: 18074541
[No Abstract] [Full Text] [Related]
47. [Methotrexate therapy in psoriasis].
Bournerias I
Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
[TBL] [Abstract][Full Text] [Related]
48. [Acute bone marrow suppression with low-dosage methotrexate].
Brussaard HE; van Eijk CL; van Toorn DW; van Seters WA; de Wit RF
Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2369-72. PubMed ID: 3696284
[No Abstract] [Full Text] [Related]
49. [Side effects of methotrexate in the treatment of skin diseases].
Ruszczak Z; Prószyńska-Kuczyńska W; Krajewski C
Wiad Lek; 1974 Jun; 27(12):1083-6. PubMed ID: 4600611
[No Abstract] [Full Text] [Related]
50. Methotrexate and the citrovorum factor in the treatment of psoriasis.
Ive FA; De Saram CF
Trans St Johns Hosp Dermatol Soc; 1970; 56(1):45-7. PubMed ID: 5312493
[No Abstract] [Full Text] [Related]
51. [Clinico-biochemical parallels in the treatment of psoriasis with small doses of methotrexate].
Nikulin NK
Vestn Dermatol Venerol; 1974 Oct; 0(10):70-4. PubMed ID: 4432620
[No Abstract] [Full Text] [Related]
52. Liver disease in psoriatics--An effect of methotrexate therapy?
Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
[No Abstract] [Full Text] [Related]
53. Intermittent high dose oral methotrexate therapy in psoriasis.
Baker H
Br J Dermatol; 1970 Jan; 82(1):65-9. PubMed ID: 5410994
[No Abstract] [Full Text] [Related]
54. Treatment of psoriasis with methotrexate and folinic acid.
Burkhart CG
J Am Acad Dermatol; 1980 Aug; 3(2):207-8. PubMed ID: 6967877
[No Abstract] [Full Text] [Related]
55. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
56. [Suppression of bone marrow after drug interaction].
Spigset O; Messner T
Lakartidningen; 1993 Jun; 90(22):2138-40. PubMed ID: 8502067
[No Abstract] [Full Text] [Related]
57. Low-dose methotrexate therapy and hepatotoxicity. The view of the hepatologist.
Watson RG; Smallwood RA
Med J Aust; 1991 Oct; 155(7):428-30. PubMed ID: 1921807
[No Abstract] [Full Text] [Related]
58. Methotrexate.
Boffa MJ
Adv Exp Med Biol; 1999; 455():341-2. PubMed ID: 10599367
[No Abstract] [Full Text] [Related]
59. Folinic acid rescue used routinely in psoriatic patients with known methotrexate "sensitivity".
Hills RJ; Ive FA
Acta Derm Venereol; 1992 Nov; 72(6):438-40. PubMed ID: 1362837
[TBL] [Abstract][Full Text] [Related]
60. Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis.
Zachariae H
Arch Dermatol; 1984 Feb; 120(2):155. PubMed ID: 6696467
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
